Article

Pre-EBRT photoselective vaporization of the prostate safe, efficacious in men with prostate cancer, BPH

Photoselective laser vaporization of the prostate performed prior to external beam radiation therapy appears to be a viable approach for managing symptomatic BPH in men with concomitant prostate cancer, according to the findings of a retrospective study.

Related Videos
Landon Trost, MD, answers a question during a video interview
Jitesh Dhingra, MD, FRCEM, answers a question during a Zoom video interview
Oliver Sartor, MD, is featured in this series.
Ravi Munver, MD, answers a question during a Zoom video interview
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
October 18th 2024

Review of residency programs identifies lack of female sexual dysfunction training

Benjamin P. Saylor
The investigators found that only 2 (1.4%) urology programs and 12 (5.3%) OB/GYN programs included female sexual dysfunction content.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
October 18th 2024

IPP placement is associated with improved penile length and width

Benjamin P. Saylor
“Before and after implant, we noted a statistically significant increase in both the length and the girth,” said Peter J. Arnold, MD.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
68Ga-PSMA and 18F-Fluciclovine demonstrate ability to alter radiation target volumes
October 16th 2024

68Ga-PSMA and 18F-Fluciclovine demonstrate ability to alter radiation target volumes

Hannah Clarke
Data from the EMPIRE-2 trial also showed that 18F-fluciclovine resulted in significantly more boosts to the prostate bed.
FDA accepts new drug application for UGN-102 in NMIBC
October 16th 2024

FDA accepts new drug application for UGN-102 in NMIBC

Hannah Clarke
The target action date for the application is June 13, 2025.
© 2024 MJH Life Sciences

All rights reserved.